Goldman Sachs’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $55.4K | Buy |
26,269
+15,570
| +146% | +$32.9K | ﹤0.01% | 4963 |
|
2025
Q1 | $13.1K | Sell |
10,699
-36,822
| -77% | -$44.9K | ﹤0.01% | 4996 |
|
2024
Q4 | $61.3K | Buy |
47,521
+14,489
| +44% | +$18.7K | ﹤0.01% | 4842 |
|
2024
Q3 | $90.8K | Buy |
33,032
+10,469
| +46% | +$28.8K | ﹤0.01% | 4610 |
|
2024
Q2 | $51K | Buy |
+22,563
| New | +$51K | ﹤0.01% | 4562 |
|
2022
Q3 | – | Sell |
-18,419
| Closed | -$24K | – | 5543 |
|
2022
Q2 | $24K | Buy |
18,419
+7,659
| +71% | +$9.98K | ﹤0.01% | 5395 |
|
2022
Q1 | $17K | Sell |
10,760
-531
| -5% | -$839 | ﹤0.01% | 5631 |
|
2021
Q4 | $23K | Sell |
11,291
-3,426
| -23% | -$6.98K | ﹤0.01% | 5444 |
|
2021
Q3 | $57K | Sell |
14,717
-3,458
| -19% | -$13.4K | ﹤0.01% | 5161 |
|
2021
Q2 | $58K | Sell |
18,175
-2,637
| -13% | -$8.42K | ﹤0.01% | 5227 |
|
2021
Q1 | $45K | Sell |
20,812
-2,349
| -10% | -$5.08K | ﹤0.01% | 5145 |
|
2020
Q4 | $52K | Buy |
23,161
+2,507
| +12% | +$5.63K | ﹤0.01% | 4556 |
|
2020
Q3 | $55K | Sell |
20,654
-140
| -0.7% | -$373 | ﹤0.01% | 4317 |
|
2020
Q2 | $64K | Buy |
20,794
+4,119
| +25% | +$12.7K | ﹤0.01% | 4233 |
|
2020
Q1 | $33K | Sell |
16,675
-15,401
| -48% | -$30.5K | ﹤0.01% | 4316 |
|
2019
Q4 | $92K | Sell |
32,076
-9,516
| -23% | -$27.3K | ﹤0.01% | 4137 |
|
2019
Q3 | $152K | Buy |
+41,592
| New | +$152K | ﹤0.01% | 3985 |
|
2019
Q2 | – | Sell |
-174,391
| Closed | -$891K | – | 4219 |
|
2019
Q1 | $891K | Buy |
174,391
+160,323
| +1,140% | +$819K | ﹤0.01% | 3323 |
|
2018
Q4 | $48K | Sell |
14,068
-1,888
| -12% | -$6.44K | ﹤0.01% | 3976 |
|
2018
Q3 | $96K | Buy |
+15,956
| New | +$96K | ﹤0.01% | 3960 |
|
2018
Q1 | – | Sell |
-12,528
| Closed | -$42K | – | 4242 |
|
2017
Q4 | $42K | Sell |
12,528
-1,521
| -11% | -$5.1K | ﹤0.01% | 4046 |
|
2017
Q3 | $30K | Sell |
14,049
-3,055
| -18% | -$6.52K | ﹤0.01% | 4166 |
|
2017
Q2 | $42K | Sell |
17,104
-267
| -2% | -$656 | ﹤0.01% | 4262 |
|
2017
Q1 | $40K | Buy |
17,371
+2,026
| +13% | +$4.67K | ﹤0.01% | 4246 |
|
2016
Q4 | $15K | Buy |
15,345
+174
| +1% | +$170 | ﹤0.01% | 4385 |
|
2016
Q3 | $17K | Sell |
15,171
-67
| -0.4% | -$75 | ﹤0.01% | 4458 |
|
2016
Q2 | $22K | Sell |
15,238
-1,043
| -6% | -$1.51K | ﹤0.01% | 4393 |
|
2016
Q1 | $23K | Sell |
16,281
-7,664
| -32% | -$10.8K | ﹤0.01% | 4354 |
|
2015
Q4 | $39K | Sell |
23,945
-18,987
| -44% | -$30.9K | ﹤0.01% | 4247 |
|
2015
Q3 | $100K | Sell |
42,932
-2,580
| -6% | -$6.01K | ﹤0.01% | 4163 |
|
2015
Q2 | $124K | Buy |
45,512
+26,476
| +139% | +$72.1K | ﹤0.01% | 4235 |
|
2015
Q1 | $64K | Buy |
19,036
+4,996
| +36% | +$16.8K | ﹤0.01% | 4247 |
|
2014
Q4 | $49K | Buy |
14,040
+2,999
| +27% | +$10.5K | ﹤0.01% | 4389 |
|
2014
Q3 | $56K | Sell |
11,041
-30,869
| -74% | -$157K | ﹤0.01% | 4350 |
|
2014
Q2 | $579K | Buy |
41,910
+36,766
| +715% | +$508K | ﹤0.01% | 3263 |
|
2014
Q1 | $79K | Buy |
+5,144
| New | +$79K | ﹤0.01% | 4175 |
|